Daito Pharmaceutical Reports First-Quarter Net Profit
For the quarter ended August 31, 2026, revenue, operating profit, pretax profit and net profit were reported. Net profit was higher than the prior-year figure; the source also reports lower revenue and operating profit year over year.
Daito Pharmaceutical Co. Ltd. 01 bln in 2025. 05 bln.
00 mln. The quarter ended August 31, 2026.